Triple DAA regimen cures hepatitis C patients with rapid response in just 3 weeks

Triple DAA regimen cures hepatitis C patients with rapid response in just 3 weeks Direct-acting antiviral agents (DAAs) used in interferon-free regimens have already brought about a revolution in treatment for chronic hepatitis C, but researchers continue to search for … Continue reading